Red Tortoise LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Red Tortoise LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$1.46K	–	589
2023 Q1	$1.46K	Buy	+10	New	+$1.48K	﹤0.01%	493

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Red Tortoise LLC's JAZZ Position: Q2 2023 in Review

Red Tortoise LLC sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 10 shares — an estimated $1.46K sold.

Red Tortoise LLC first reported a position in JAZZ in Q1 2023 and held it in 1 quarter. The position peaked at $1.46K in Q1 2023. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

Red Tortoise LLC reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Red Tortoise LLC sold 10 Jazz Pharmaceuticals shares in Q2 2023, an estimated $1.46K.
Red Tortoise LLC first reported a position in Jazz Pharmaceuticals in Q1 2023 and held it in 1 quarter.
Red Tortoise LLC's Jazz Pharmaceuticals position peaked at $1.46K in Q1 2023.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Red Tortoise LLC's 13F filing for Q2 2023, filed 26 Jul 2023.